Your browser doesn't support javascript.
loading
Impact of PSMA PET on Prostate Cancer Management.
Weiner, Adam B; Agrawal, Raag; Valle, Luca F; Sonni, Ida; Kishan, Amar U; Rettig, Matthew B; Raman, Steven S; Calais, Jeremie; Boutros, Paul C; Reiter, Robert E.
Afiliação
  • Weiner AB; Department of Urology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA. abweiner@mednet.ucla.edu.
  • Agrawal R; Institute for Precision Health, University of California-Los Angeles, Los Angeles, CA, USA. abweiner@mednet.ucla.edu.
  • Valle LF; Institute for Precision Health, University of California-Los Angeles, Los Angeles, CA, USA.
  • Sonni I; Department of Human Genetics, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA.
  • Kishan AU; Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles, CA, USA.
  • Rettig MB; Department of Radiation Oncology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA.
  • Raman SS; Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, USA.
  • Calais J; Department of Radiological Sciences, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA.
  • Boutros PC; Department of Clinical and Experimental Medicine, University Magna Graecia, Catanzaro, Italy.
  • Reiter RE; Department of Radiation Oncology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA.
Curr Treat Options Oncol ; 25(2): 191-205, 2024 02.
Article em En | MEDLINE | ID: mdl-38270802
ABSTRACT
OPINION STATEMENT PSMA-PET has been a practice-changing imaging biomarker for the management of men with PCa. Research suggests improved accuracy over conventional imaging and other PET radiotracers in many contexts. With multiple approved PSMA-targeting radiotracers, PSMA PET will become even more available in clinical practice. Its increased use requires an understanding of the prospective data available and caution when extrapolating from prior trial data that utilized other imaging modalities. Future trials leveraging PSMA PET for treatment optimization and management decision-making will ultimately drive its clinical utility.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article